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Abstract
Chlamydophila pneumoniae causes acute respiratory tract infections and has been associated with development of asthma
and atherosclerosis. The production of IL-1b, a key mediator of acute and chronic inflammation, is regulated on a
transcriptional level and additionally on a posttranslational level by inflammasomes. In the present study we show that C.
pneumoniae-infected human mononuclear cells produce IL-1b protein depending on an inflammasome consisting of NLRP3,
the adapter protein ASC and caspase-1. We further found that the small GTPase Rac1 is activated in C. pneumoniae-infected
cells. Importantly, studies with specific inhibitors as well as siRNA show that Rac1 regulates inflammasome activation in C.
pneumoniae-infected cells. In conclusion, C. pneumoniae infection of mononuclear cells stimulates IL-1b production
dependent on a NLRP3 inflammasome-mediated processing of proIL-1b which is controlled by Rac1.
Citation: Eitel J, Meixenberger K, van Laak C, Orlovski C, Hocke A, et al. (2012) Rac1 Regulates the NLRP3 Inflammasome Which Mediates IL-1beta Production in
Chlamydophila pneumoniae Infected Human Mononuclear Cells. PLoS ONE 7(1): e30379. doi:10.1371/journal.pone.0030379
Editor: David M. Ojcius, University of California Merced, United States of America
Received May 27, 2011; Accepted December 19, 2011; Published January 20, 2012
Copyright:  2012 Eitel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Deutsche Forschungsgemeinschaft (OP 86/5-1, OP 86/7-1, SFB/TR84 project A1 to B.O., and SFB/TR84 project Z1a to
A.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: bastian.opitz@charite.de
. These authors contributed equally to this work.
Introduction
Chlamydophila pneumoniae is a gram-negative, obligate intracellu-
lar bacterium that causes acute respiratory tract infections
including pneumonia, sinusitis, and bronchitis. Moreover,
chronic or recurrent C. pneumoniae infections have been associated
with development of chronic lung diseases such as asthma [1] as
well as with development of vascular lesions and atherosclerosis
[2–5]. Chlamydiae undergo a biphasic developmental cycle inside
an internalized vesicle termed inclusion. The virulent and
metabolically inert elementary bodies (EBs) differentiate into
the non-virulent and metabolically active reticulate bodies (RBs),
re-differentiate to EBs and finally escape from the host cell. C.
pneumoniae is able to reside and replicate in different cell types
such as monocytes, macrophages, smooth muscle cells and
endothelial cells, and often persists intracellularly for indefinite
periods [6].
The innate immune system senses microbial pathogens by
pattern recognition receptors (PRRs) including the membrane-
bound Toll-like receptors (TLRs) and C-type lectin receptors
(CLRs), as well as the cytosolic RIG-like receptors (RLRs) and
NOD-like receptors (NLRs) [7–9]. The TLRs, RLRs as well as
some NLRs like NOD1/NLRC1 and NOD2/NLRC2 activate a
NF-kB-dependent expression of proinflammatory genes including,
for example, TNFa and proIL-1b. In contrast, other NLRs like
NLRC4 (also called IPAF), NLRP1 and NLRP3 are involved in
the assembly of a multiprotein complex called inflammasome,
which also contains the adaptor molecule ASC (apoptosis
associated speck-like protein containing a caspase activation
recruitment domain) and caspase-1. Inflammasomes mediate
caspase-1 activation leading to cleavage of proIL-1b and proIL-
18 into their active forms [10]. Inflammasomes are activated by a
variety of pathogens and endogenous danger signals. The NLRP3
inflammasome, for example, is stimulated by bacteria expressing
pore-forming toxins or secretion systems [11–19], uric acid
crystals, ATP, silica crystals and aluminium salts [16,20–22].
While it is unlikely that these different stimuli directly bind to
NLRP3, the precise signal that is detected by NLRP3 has not been
unambiguously identified.
The Rho family GTPase Rac1 is a key regulator of various
cellular functions such as cytoskeletal reorganization or cellular
growth [23–25]. It is also implicated in different aspects of
antibacterial host defense, including leukocyte chemotaxis [24],
pathogen phagocytosis [26,27], ROS production [28], and
regulation of TLRs and NOD2 [29–32].
Chlamydia infection is detected by TLR2 and TLR4 [33–36] at
the plasma membrane, and by NOD1 and NOD2 in the cytosol
[37–40] which leads to stimulation of pro-inflammatory gene
expression. Additionally, a yet-to-be-identified cytosolic PRR
activates type I IFN production upon sensing of Chlamydia species
[41,42].
In this study, we demonstrate that the NLRP3 inflammasome
regulates IL-1b production in C. pneumoniae-infected human
monocytes. The data further show that the small GTPase Rac1
controls the C. pneumoniae-stimulated inflammasome activation.
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Ethics statement
Studies with human PBMCs were approved by the ethics
committee of the Charite ´-Universita ¨tsmedizin Berlin. Written
informed consent from all participants was obtained. This study
was carried out in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of the
Committee of animal welfare commissioners in Berlin, Germany.
The protocol was approved by the Committee on the Ethics of
Animal Experiments of the Charite ´-Universita ¨tsmedizin Berlin
and the governmental institutions (LAGeSo, Permit Number: T
0013/11).
Bacterial strains
The C. pneumoniae strain CWL029 (ATCC VR-1310) was
cultured and purified in HEp-2 cells as described by Maass et al.
[3]. Isolated PBMCs or cultured THP-1 cells and BMMs were
inoculated with C. pneumoniae using a multiplicity of infection
(MOI) of 0.5 to 5. Plates were centrifuged at 800 g at 37uC for
1 hour and subsequently incubated for different time intervals.
Human cell culture
The human monocyte cell line THP-1 was obtained from
DSMZ. Cells were cultured in RPMI 1640 containing 5% FCS
(Gibco) and seeded in appropriate culture dishes at a concentra-
tion of 10
6 cells/ml. THP-1 were left untreated or adhered o/n
with 100 ng/ml PMA (Sigma-Aldrich) and cultured two more
days before infection. Human PBMCs were isolated from buffy
coat preparations obtained from the German Red Cross Berlin.
The buffy coat was diluted with RPMI 1640 containing 5% FCS
and 0.2 mM EDTA, and centrifuged twice over Pancoll (PAN
Biotech) for 25 min at 8006g. Cells were cultured in RPMI 1640
containing 10% FCS and seeded in appropriate culture dishes at a
concentration of 5*10
6 cells/ml. In some experiments, human
PBMCs or THP-1 cells were preincubated for 30 min with 25 or
50 mM NSC23766 (Calbiochem, San Diego, CA), or substances
were added 2.5 h post-infection.
Generation of mouse BMMs
The protocol was approved by the Committee on the Ethics of
Animal Experiments of the Charite ´-Universita ¨tsmedizin Berlin
and the governmental institutions (LAGeSo, Permit Number: T
0013/11). Wildtype C57BL/6 mice were purchased from Charles
River. Nlrp3 knockout mice were kindly provided by Professor
Ju ¨rg Tschopp, University of Lausanne [22]. Bone marrow-derived
macrophages (BMMs) were cultured in RPMI 1640 containing
30% L cell supernatant and 20% FBS, and were replated one day
prior to infection in RPMI 1640 containing 15% L cell
supernatant and 10% FBS.
RNA interference
THP-1 cells were transfected using the Amaxa Nucleofector
(Amaxa) according to the manufacturer’s protocol (Cell Line
Nucleofector Kit V, Program T-08) with 2 mg per 10
6 cells.
Human PBMCs were transfected using the Amaxa Nucleofector
according to the manufacturer’s protocol (Human Monocyte
Nucleofector Kit, Program Y-01) with 4 mg siRNA per 10
7 cells
[30]. Control non-silencing small interfering RNA (siRNA) (sense
UUCUCCGAACGUGUCACGUtt, antisense ACGUGACAC-
GUUCGGAGGAGAAtt), and siRNAs targeting ASC (sense
GAUGCGGAAGCUCUUCAGU, antisense ACUGAAGAG-
CUUCCGCAUC), NLRP3 (sense GGUGUUGGAAUUAGA-
CAAC, antisense GUUGUCUAAUUCCAACACC), and cas-
pase-1 (sense GGUUCGAUUUUCAUUUGAG, antisense
CUCAAAUGAAAAUCGAACC) were purchased from Ambion
(Austin, TX). Rac1 (sense CACCACUGUCCCAACACUC,
antisense GAGUGUUGGGACAGUGGUG) were purchased
from MWG-Biotech AG.
Western Blot
Cell-free supernatants were concentrated using Microcon
Ultracel YM-3 Centrifugal Filter Devices (Millipore). Cell extracts
or concentrated supernatants were separated by SDS-PAGE and
blotted. Membranes were first exposed to antibodies specific for
IL-1b (Cell Signaling Technology, Beverly, MA), Caspase-1 (Cell
Signaling Technology) or Rac1 (BD Transduction Laboratories),
and subsequently incubated with secondary antibodies (HRP-
labelled anti-rabbit (Santa Cruz Biotechnology Santa Cruz, CA) or
Cy5.5-labelled anti-mouse). Proteins were detected by Chemilu-
minescence (Pierce, USA) or using the Odyssey Infrared Imaging
System (LI-COR).
ELISA
Concentrations of IL-1b or mIL-1b in cell-free supernatants
were quantified by commercially available sandwich ELISA Kits
(BD Biosciences, eBioscience).
PCR Analysis
Total RNA from THP-1 or human PBMCs was isolated using
RNeasy Kit (Qiagen) and reverse transcribed with High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems). The
generated cDNA was amplified by semi-quantitative PCR using
REDTaq DNA Polymerase (Sigma-Aldrich) and specific primers,
or by quantitative PCR using TaqMan Gene Expression Assays
(Applied Biosystems) on the 7300 Real Time PCR System
(Applied Biosystems). The mRNA expression level of each target
gene was normalized to the expression level of GAPDH. For
measurements of chlamydial 16s rRNA, total RNA was isolated
with the RNeasy Mini kit (Qiagen). The extracted RNA was
treated with DNase I (Qiagen) to eliminate the contaminating
eukaryotic DNA. After reverse transcription, relative quantifica-
tion of C. pneumoniae 16S rRNA (accession number U68426, www.
ebi.ac.uk/embl; sense, 59-ATGTGGATGGTCTCAACCCCAT-
39; antisense, 59-GGCGCCTCTCTCCTATAAATAGG-39) was
carried out in a real-time PCR, using SYBR-Green PCR Master-
Mix (Applied Biosystems, Foster City, CA) and normalized to
GAPDH of the same samples.
Confocal laser scanning microscopy
THP-1 cells were seeded on coverslips and left untreated or
were infected with C. pneumoniae (MOI 2) in the presence or
absence of NSC23766. After 20 h, cells were fixed with 3%
paraformaldehyde (Sigma-Aldrich). Cells were permeabilized with
1% Triton X-100 (Sigma-Aldrich) and blocked with 5% goat
serum (Invitrogen). Chlamydia and ASC were stained by exposing
cells to specific Abs (Dako Cytomation, Cambridgeshire and Santa
Cruz Biotechnology), followed by incubation with AF546-
conjugated anti-mouse IgG and AF488-conjugated anti-rabbit
IgG, respectively (Invitrogen). Confocal laser scanning microscopy
was conducted on a LSM5 Pascal (Zeiss).
C. pneumonia quantification
For HEp-2 reinfection assays, THP-1 cells transfected with
control (c-siRNA) or Rac1 siRNA were exposed to C. pneumoniae
(MOI 0.5). After 72 h, cells were washed with PBS, scraped off
into medium, and rigorously vortexed with glass beads to release
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to pellet cellular debris and passaged onto HEp-2 cells seeded on
glass coverslips. At 48 h postinfection (p.i.), cells were fixed and
immunolabeled with anti–Chlamydia-LPS Ab as described above.
Cells were analyzed using a Pascal 5 confocal laser scanning
microscope (Zeiss, Jena, Germany) and C. pneumoniae inclusions per
well were counted.
Statistical analysis
Effects of siRNAs were statistically evaluated by a one-way
ANOVA and compared by a Newman-Keul’s post-test. Through-
out the figures, p,0.05 is indicated by one asterisk and p,0.01 is
indicated by double asterisks.
Results
C. pneumoniae stimulates production of mature IL-1b in
human monocytic cells
First, we infected peripheral blood mononuclear cells (PBMCs)
and THP-1 cells with different MOIs (multiplicity of infection) of
C. pneumoniae strain CWL029. Chlamydia infection dose-dependent-
ly stimulated IL-1b production in both cell types (Fig. 1A and data
not shown). Furthermore, PBMCs were infected with C. pneumoniae
(MOI 5) at different time points and accumulation of mature IL-
1b in the cell supernatant was demonstrated by Western blot
(Fig. 1B).
The C. pneumoniae-induced IL-1b secretion depended on
the NLRP3 inflammasome
The primary function of inflammasomes is to convert inactive
pro-caspase-1 into the active, cleaved enzyme which subsequently
processes proIL-1b into IL-1b. C. pneumoniae infection leads to
cleavage and therefore activation of caspase-1 (Fig. 2A). We
verified the role of caspase-1 activation for C. pneumoniae-mediated
IL-1b release using siRNA specific for caspase-1. Knockdown of
caspase-1 in PBMCs (Fig. 2B) clearly reduced the Chlamydia-
induced secretion of IL-1b (Fig. 2C). Moreover, ASC and NLRP3
siRNAs strongly attenuated expression of their corresponding
transcripts, and lowered the IL-1b production in C. pneumoniae-
infected cells (Fig. 2D,E, F, G). ASC and NLRP3 siRNAs also
inhibited activation of caspase-1 (Fig. 2H). In order to verify the
involvement of NLRP3 in C. pneumoniae-induced secretion of IL-
1b, we infected bone-marrow macrophages (BMMs) from wildtype
and Nlrp3 knockout mice with C. pneumoniae. Our results showed
that upon infection wildtype BMMs produced IL-1b whereas IL-
1b production in the Nlrp3 knockout macrophages was completely
abolished (Fig. 2I). These results collectively show that the NLRP3
inflammasome regulates IL-1b production at the level of caspase-1
in C. pneumoniae-infected host cells.
Rac1 is essential for C. pneumoniae-induced
inflammasome activation and IL-1b production in human
monocytes
Since Rac1 has been implicated in the regulation of different
innate immune pathways, we analysed the role of Rac1 in the C.
pneumoniae-stimulated IL-1b production. We preincubated PBMCs
with the specific Rac1 inhibitor NSC23766 and subsequently
infected them with C. pneumoniae at a MOI of 3. Inhibition of Rac1
decreased IL-1b release in a dose-dependent manner (Fig. 3A).
Moreover, the Rac1 inhibitor also reduced the IL-1b production
in C. pneumoniae–infected cells when added 2.5 hrs post infection
(Fig. 3C). In order to rule out the possibility that reduced IL-1b
production was a result of diminished bacterial load in the cells, we
measured the chlamydial 16s rRNA in all samples via Q-PCR.
The data show that inhibition of Rac1 did not influence bacterial
numbers in the cells (Fig. 3B, D). Moreover, reinfection of HEp-2
cells, with lysates of THP-1 cells transfected with Rac1 siRNA and
subsequently infected with C. pneumoniae, also demonstrated a
similar number of inclusions compared with control siRNA treated
cells (Fig. 3E, F).
To substantiate our findings, we transfected PBMCs with
control or Rac1-specific siRNA and infected them with C.
pneumoniae. We found that Rac1 siRNA strongly diminished
Rac1 mRNA expression (Fig. 4A). Rac1 siRNA clearly reduced
C. pneumoniae-mediated IL-1b secretion (Fig. 4B), but did not affect
induction of proIL-1b mRNA (Fig. 4C). Together, the results show
that Rac1 regulates the C. pneumoniae-stimulated IL-1b production
at a posttranscriptional level, but did not influence bacterial uptake
in the cells examined.
To determine if Rac1 has an influence on the activation of
caspase-1, we incubated the cells with the Rac1 inhibitor
NSC23766, infected them with C. pneumoniae and analysed
caspase-1 activation in cell lysates. As shown in Figure 4D,
NSC23766 dose-dependently inhibited the C. pneumoniae-stimulat-
ed activation of caspase-1. Recent studies showed that in cells
stimulated with inflammasome agonists or infected with different
Figure 1. C. pneumoniae stimulates production of mature IL-1b in human PBMCs. (A) Human PBMCs were infected with different MOI of C.
pneumoniae for 16 hrs and production of IL-1b was determined by ELISA. (B) Human PBMCs were infected with C. pneumoniae (MOI 3) for different
time intervals and amounts of mature IL-1b (17 kDA) in the cell supernatant was visualized by Western Blot. The western blot is representative of
three independent experiments. Results obtained from ELISAs represent mean 6 SD of three independent experiments.
doi:10.1371/journal.pone.0030379.g001
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investigated whether similar foci-like structures could be detected
in C. pneumoniae-infected THP-1 cells. Immunofluorescence
microscopy revealed that C. pneumoniae infection triggered the
assembly of ASC foci (Fig. 4E, F). Interestingly, Rac1 inhibition by
NSC23766 reduced the relocalization of ASC into distinct foci
(Fig. 4E, F). Collectively, the results suggest that Rac1 regulates
inflammasome activation in C. pneumoniae-infected monocytes
upstream of ASC and caspase-1.
Discussion
IL-1b is a key mediator of acute and chronic infections, and is
therefore tightly controlled at different levels. This ensures that IL-
1b is not inappropriately released, since this could have deleterious
consequences for the host. We examined the posttranslational
regulation of IL-1b production by inflammasomes in C. pneumo-
phila-infected cells. Our data show that the NLRP3 inflammasome
mediates the processing of proIL-1b into IL-1b. Importantly, we
provide evidence for a regulation of the NLRP3 inflammasome by
the small GTPase Rac1.
It has been shown that Chlamydia-infected monocytes and
macrophages secrete IL-1b and this process requires caspase-1
[45–47]. Our results add to this by showing that the C. pneumoniae-
stimulated IL-1b production in human PBMCs and murine BMMs
was mediated by an inflammasome composed of NLRP3, ASC and
caspase-1.Thisisinlinewithrecent studiesshowingthatinfectionof
cells with C. trachomatis and C. pneumoniae led to activation of caspase-
Figure 2. Caspase-1, ASC and NLRP3 mediate IL-1b production in C. pneumoniae-infected cells. (A) THP-1 monocytes were infected with C.
pneumoniae (MOI 3) for different time intervalls. Cell lysates were harvested and assayed for procaspase-1 and caspase-1 p20. (B, C) PBMCs were
transfected with control siRNA or siRNA specific for caspase-1. After 48 h, cells were infected with C. pneumoniae (MOI 3) for 16 hrs. Expression of
caspase-1 was examined by reverse transcription PCR, and supernatants were subjected to IL-1b ELISA. (D–G) PBMCs were transfected with control
siRNA or siRNA specific for ASC (D, E) or NLRP3 (F, G). After 48 h, cells were infected with C. pneumoniae (MOI 3), expression of ASC (D) and NLRP3 (F)
was examined by reverse transcription PCR, and supernatants were subjected to IL-1b ELISA (E, G). (H) Cells were transfected with siRNA as indicated
and, after 48 h, infected with C. pneumoniae (MOI 3). Cell lysates were assayed for procaspase-1 and caspase-1 p20. (I) Mouse BMMs obtained from
wildtype and Nlrp32/2 mice were infected with C. pneumoniae (MOI 3) for 16 hrs. Production of mIL-1b was quantified by ELISA. Western Blots are
representative for at least three independent experiments. Results obtained from ELISAs represent mean 6 SD of three independent experiments.
doi:10.1371/journal.pone.0030379.g002
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further showed that upon infection with C. pneumoniae ASC foci
formation occurs, which is consistent with a recent study
demonstrating that infection with S. typhimurium or F. novicida causes
ASC relocalization in distinct foci [43]. These foci have been
suggested to represent the sites of IL-1b and IL-18 processing [43].
Our study has characterizes a mechanism of inflammasome
regulation. We found that Rac1 was activated in C. pneumoniae-
Figure 3. Role of Rac1 in the production of IL-1b in C. pneumoniae-infected cells. (A) PBMCs were incubated with different concentrations of
the Rac1 inhibitor NSC23766 for 30 min and subsequently infected with C. pneumoniae (MOI 3), or (C) cells were first infected with C. pneumoniae
(MOI 3) and NSC23766 was added 2.5 h post-infection. After incubating 16 hrs production of IL-1b was quantified by ELISA. Total RNA was harvested
for quantification of chlamydial 16s rRNA production (B, D) using real-time PCR as indicated in the Materials and Methods section. (E) THP-1 cells were
transfected with control siRNA or siRNA specific for Rac1. After 48 h, cells were infected with C. pneumoniae (MOI 3) for 16 hrs and knock down of
Rac1 was assessed by reverse transcription PCR. (F) HEp-2 reinfection assay in which siRNA-transfected THP-1 cells infected with C. pneumoniae (MOI
0.5; 72 h) were harvested and inoculated onto monolayers of HEp-2 cells. Infected cells were then stained for Chlamydia 48 h p.i. and clamydial
inclusions were counted. Data shown are representative for at least three (A–D) or two (E, F) experiments performed in duplicates.
doi:10.1371/journal.pone.0030379.g003
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activation and production of IL-1b in these cells were dependent
on Rac1. Rac1 was not required for expression of proIL-1b.
Several pathogens engage both Rho GTPases and caspase-1 to
influence the host [51,52]. Yersinia bacteria, for instance, can
prevent host caspase-1 activation and IL-1b release by targeting
Rac1 with type III effector proteins [53]. On the other hand, the
Salmonella enterica serovar Typhimurium type III effector protein
SopE activates Rac1 and thus leads to caspase-1 activation and
subsequent maturation and secretion of IL-1b [54]. A Rac1-
dependent regulation of inflammasomes might therefore be a
common phenomenon in cells infected with pathogenic bacteria.
However, the signalling pathway connecting Rac1 and caspase-1
is not understood. Rac1 might regulate NLRP3 inflammasome
activation via controlling production of reactive oxygen species
[55]. Moreover, the Rac1 interaction partner LIM kinase has been
Figure 4. Rac1 controls IL-1b production at a posttranscriptional level in C. pneumoniae-infected cells. PBMCs were transfected with
control siRNA or siRNA specific for Rac1. After 48 h, cells were infected with C. pneumoniae (MOI 3) for 16 hrs and knock down of Rac1 was assessed
by reverse transcription PCR (A). Cell supernatants were subjected to IL-1b ELISA (B), and levels of pro-IL-1b mRNA were analyzed by Q-PCR (C). (D)
THP-1 cells were incubated with the indicated concentrations of NSC23766 for 30 min and afterwards infected with C. pneumoniae (MOI 3) for 8 h.
Cell lysates were assayed for pro-caspase-1 and caspase-1 p20 by Western blot. The western Blot is representative of three independent experiments.
(E, F) THP-1 cells seeded on coverslips were treated or not treated with NSC23766, and infected with C. pneumoniae for 20 h. Bacteria (red) and ASC
(green) were visualized by confocal laser scanning microscopy using specific antibodies. The arrowheads point to ASC foci. Images are representative
of three independent experiments (original magnification 636).
doi:10.1371/journal.pone.0030379.g004
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the Rac1 effector ‘‘p21 activated kinase 1’’ and caspase-1 has been
suggested [56]. Further studies examining the links between Rac1
and inflammasomes are required to fully understand their
interaction in bacterial infections.
Taken together, the IL-1b production in C. pneumoniae-infected
monocytic cells relies on the NLRP3 inflammasome. Our finding
that Rac1 controls the inflammasome activation adds to the
understanding of this important innate immune pathway.
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